Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evera Medical was a medical technology company specializing in the development of advanced soft tissue fillers and regenerative scaffolds for aesthetic and reconstructive surgery. Its core technology featured a three-dimensional scaffold designed to support natural tissue ingrowth, offering a potentially permanent and more natural alternative to traditional synthetic implants or temporary fillers. The company's primary focus was on applications for breast augmentation and the repair of soft tissue defects. In 2014, Evera Medical was acquired by Allergan, integrating its innovative tissue-regeneration platform into Allergan's market-leading aesthetics portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evera Medical.